An overactive thyroid can affect your eyes, skin, nails, heart, weight, mood, and even your bones. In this video, we break ...
Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the main goal of a late-stage trial in chronic patients, sending its shares up nearly 50% before the bell. The drug ...
By Siddhi Mahatole May 5 (Reuters) - Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the ...
Among patients with autoimmune hyperthyroidism, those who use cannabis are 1.9 times more likely to develop exophthalmos — eyes that appear to bulge from the face — within 1 year of diagnosis, than ...
New research suggests that progression of thyroid eye disease is not limited to the early disease period, with a number of ...
Viridian Therapeutics' shares rose after the company said its treatment for thyroid eye disease met its primary endpoint in a recent trial. The stock gained 58% to $22.30 in premarket trading Tuesday.
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced new pooled efficacy data from the Phase 2 and 3 clinical trials of TEPEZZA™ (teprotumumab-trbw) showing that the ...
An injectable monoclonal antibody that targets the insulin-like growth factor I receptor improved proptosis in more than half ...
If you have thyroid eye disease (TED), you may have experienced emotional or mental issues, such as anxiety, body image distress, depression, and emotional exhaustion, that are often associated with ...
Whereas earlier Phase 3 results disappointed Wall Street, new findings in people with “chronic” disease were viewed by ...
Daisy Ridley, 32, stunningly revealed this week that she has Graves’ disease. The “Star Wars” actress shared that after experiencing hot flashes, a racing heart rate, weight loss and fatigue, she was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results